Welcome Introduction: The Evolving Science and Medicine of Antiplatelet Therapy
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI

Antiplatelet Therapy in PCI: Focus on Addressing the Triple End Points of Thrombosis, Bleeding and Mortality-Connecting Evidence Across Recent Landmark Studies
Shamir Mehta, MD, MSc, FACC, FRCPC

New Paradigms and Challenges in Antiplatelet Management: Platelet Response Variability, Combination Therapy with PPIs, and Pharmacogenomics
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI

Antiplatelet Therapy in High Risk Populations: Does One Size Fit All?
Harold L. Dauerman, MD, FACC

Bleeding is the Red Line in the Sand for Antiplatelet Therapy: Avoiding Complications in the Cardiac Cath Lab and Beyond-What Works? What Might Work? What Doesn’t?
Sunil V. Rao, MD, FACC

Clots, Catheters, and Complications: Case Studies in Antiplatelet Management-Clinical Decisions and Real World Outcomes: Questions and Answers
Faculty Panel